The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

Cancer and Metastasis Reviews

Volumn 29, Issue 4, 2010, Pages 613-639

  Boominathan, Lakshmanane ^a  

^a Genome Discovery   (India)

Author keywords

c myc; CSCs; Metastasis; miRNAs; p53 p73 p63; PTEN

Indexed keywords

B RAF KINASE; BUB1 RELATED PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; EPIDERMAL GROWTH FACTOR RECEPTOR; HIGH MOBILITY GROUP A2 PROTEIN; K RAS PROTEIN; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN INK4A; PROTEIN INK4B; PROTEIN LET 7; PROTEIN LIN28; PROTEIN P130; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN TRIM32; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENOME; HUMAN; METASTASIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 78449297894     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-010-9257-9     Document Type: Review

References (260)

1. L Boominathan 2007 Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors Molecular Cancer 6 27 17407586
2. HZ Chen SY Tsai G Leone 2009 Emerging roles of E2Fs in cancer: an exit from cell cycle control Nat Rev Cancer 9 11 785 97 1:CAS:528:DC%2BD1MXhtlSjtbfE 19851314
3. P Puig P Capodieci M Drobnjak D Verbel C Prives C Cordon-Cardo, et al. 2003 p73 expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer Clinical Cancer Research 9 15 5642 5651 1:CAS:528:DC%2BD3sXpsVejur0%3D 14654547
4. MJ Urist CJ Di Como ML Lu E Charytonowicz D Verbel CP Crum, et al. 2002 Loss of p63 expression is associated with tumor progression in bladder cancer The American Journal of Pathology 161 4 1199 1206 1:CAS:528:DC%2BD38Xotlyqu7w%3D 12368193
5. BJ Park SJ Lee JI Kim SJ Lee CH Lee SG Chang, et al. 2000 Frequent alteration of p63 expression in human primary bladder carcinomas Cancer Research 60 13 3370 3374 1:CAS:528:DC%2BD3cXkvFChsr8%3D 10910040
6. M Oya WA Schulz 2000 Decreased expression of p57(KIP2)mRNA in human bladder cancer British Journal of Cancer 83 5 626 631 1:CAS:528: DC%2BD3cXmvVCgsrk%3D 10944603
7. E Kunze M Wendt T Schlott 2006 Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas International Journal of Molecular Medicine 18 4 547 557 1:CAS:528:DC%2BD28XhtV2rtrfI 16964403
8. JM Moreira P Gromov JE Celis 2004 Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition Molecular & Cellular Proteomics 3 4 410 419 1:CAS:528:DC%2BD2cXivFCksLk%3D
9. MA Le Frère-Belda D Cappellen A Daher S Gil-Diez-de-Medina F Besse CC Abbou, et al. 2001 p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours British Journal of Cancer 85 10 1515 1521 11720438
10. LS Pymar FM Platt JM Askham EE Morrison MA Knowles 2008 Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms Human Molecular Genetics 17 13 2006 2017 1:CAS:528:DC%2BD1cXntFOktbc%3D 18397877
11. A Vecchione H Ishii G Baldassarre P Bassi F Trapasso H Alder, et al. 2002 FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells The American Journal of Pathology 160 4 1345 1352 1:CAS:528:DC%2BD38XjsFGjtrk%3D 11943719
12. H Tsuruta H Kishimoto T Sasaki Y Horie M Natsui Y Shibata, et al. 2006 Hyperplasia and carcinomas in PTEN-deficient mice and reduced PTEN protein in human bladder cancer patients Cancer Research 66 17 8389 8396 1:CAS:528:DC%2BD28XovF2isr0%3D 16951148
13. EJ Kim YJ Kim P Jeong YS Ha SC Bae WJ Kim 2008 Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor Urology 180 3 1141 1145 1:CAS:528:DC%2BD1cXhtVKmsbbL
14. MS Ostenfeld JB Bramsen P Lamy SB Villadsen N Fristrup KD Sørensen, et al. 2010 miR-145 induces caspase-dependent and-independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors Oncogene 29 7 1073 1084 1:CAS:528:DC%2BD1MXhsVWlsbzI 19915607
15. Wiklund, E.D., Bramsen, J.B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T.B., et al. (2010). Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer (in press)
16. F Yu H Yao P Zhu X Zhang Q Pan C Gong, et al. 2007 let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 6 1109 1123 1:CAS:528:DC%2BD1cXksFGgtQ%3D%3D 18083101
17. L Mo X Zheng HY Huang E Shapiro H Lepor C Cordon-Cardo, et al. 2007 Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis The Journal of Clinical Investigation 117 2 314 325 1:CAS:528:DC%2BD2sXhs1Oqsbo%3D 17256055
18. MA Knowles FM Platt RL Ross CD Hurst 2009 Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer Cancer and Metastasis Reviews 28 3-4 305 316 1:CAS:528:DC%2BC3cXkt1eksA%3D%3D 20013032 Review
19. R Tomasini K Tsuchihara M Wilhelm M Fujitani A Rufini CC Cheung, et al. 2008 TAp73 knockout shows genomic instability with infertility and tumor suppressor functions Genes & Development 22 19 2677 2691 1:CAS:528:DC%2BD1cXht1ClsbvK
20. L He C Fan X Ning X Feng Y Liu B Chen, et al. 2008 Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer Cell Biology International 32 10 1302 1309 1:CAS:528:DC%2BD1cXhtF2rsL3N 18703154
21. JW Zhu SJ Field L Gore M Thompson H Yang Y Fujiwara, et al. 2001 E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis Molecular and Cellular Biology 2001 24 8547 8564
22. R Opavsky SY Tsai M Guimond A Arora J Opavska B Becknell, et al. 2007 Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis Proceedings of the National Academy of Sciences of the United States of America 104 39 15400 15405 1:CAS:528:DC%2BD2sXhtFWrtL7N 17881568
23. LS Friedman FC Thistlethwaite KJ Patel VP Yu H Lee AR Venkitaraman, et al. 1998 Thymic lymphomas in mice with a truncating mutation in Brca2 Cancer Research 58 7 1338 1343 1:CAS:528:DyaK1cXit1elu78%3D 9537225
24. AP Szremska L Kenner E Weisz RG Ott E Passegué M Artwohl, et al. 2003 JunB inhibits proliferation and transformation in B-lymphoid cells Blood 102 12 4159 4165 1:CAS:528:DC%2BD3sXpsFalsL8%3D 12907453
25. E Passegué EF Wagner 2000 JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression The EMBO Journal 19 12 2969 2979 10856241
26. E Passegué W Jochum M Schorpp-Kistner U Möhle-Steinlein EF Wagner 2001 Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage Cell 104 1 21 32 11163237
27. E Passegué EF Wagner IL Weissman 2004 JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells Cell 119 3 431 443 15507213
28. PG Corn SJ Kuerbitz MM van Noesel M Esteller N Compitello SB Baylin, et al. 1999 Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation Cancer Research 59 14 3352 3356 1:CAS:528:DyaK1MXks1Oms74%3D 10416592
29. H Yamaguchi K Inokuchi Y Sakuma K Dan 2001 Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia Leukemia 11 1729 1734
30. A Marreiros K Dudgeon V Dao MO Grimm R Czolij M Crossley, et al. 2005 KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells Oncogene 24 4 637 649 1:CAS:528:DC%2BD2MXltVSnuw%3D%3D 15580298
31. MI Koster S Kim J Huang T Williams DR Roop 2006 TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis Developmental Biology 289 1 253 261 1:CAS:528:DC%2BD2MXhtlaitr%2FL 16324689
32. H Li GS Watts MM Oshiro BW Futscher FE Domann 2006 AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells Oncogene 25 39 5405 5415 1:CAS:528:DC%2BD28XovVyhsLg%3D 16636674
33. DC Mitchell M Abdelrahim J Weng LJ Stafford S Safe M Bar-Eli, et al. 2006 Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1 The Journal of Biological Chemistry 281 1 51 58 1:CAS:528:DC%2BD28Xht1CjsQ%3D%3D 16260418
34. M Sanchez-Carbayo P Capodieci C Cordon-Cardo 2003 Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome The American Journal of Pathology 162 2 609 617 1:CAS:528:DC%2BD3sXhtlKqsr8%3D 12547718
35. M Dews A Homayouni D Yu D Murphy C Sevignani E Wentzel, et al. 2006 Augmentation of tumor angiogenesis by a Myc-activated miRNA cluster Nature Genetics 38 9 1060 1065 1:CAS:528:DC%2BD28XovVWjsbk%3D 16878133
36. SP Wang WL Wang YL Chang CT Wu YC Chao SH Kao, et al. 2009 p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug Nature Cell Biology 6 694 704
37. SO Lim H Kim G Jung 2010 p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma FEBS Letters 584 11 2231 2236 1:CAS:528:DC%2BC3cXmsVOitbw%3D 20385133
38. C Kudo-Saito H Shirako T Takeuchi Y Kawakami 2009 Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells Cancer Cell 15 3 195 206 1:CAS:528:DC%2BD1MXltFSmtbg%3D 19249678
39. S Beach H Tang S Park AS Dhillon ET Keller W Kolch, et al. 2008 Snail is a repressor of RKIP transcription in metastatic prostate cancer cells Oncogene 27 15 2243 2248 1:CAS:528:DC%2BD1cXktFCnsL4%3D 17952120
40. H Jin Y Yu T Zhang X Zhou J Zhou L Jia, et al. 2010 Snail is critical for tumor growth and metastasis of ovarian carcinoma International Journal of Cancer 126 9 2102 2111 1:CAS:528:DC%2BC3cXisFemtbc%3D
41. S Dangi-Garimella J Yun EM Eves M Newman SJ Erkeland SM Hammond, et al. 2009 Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7 The EMBO Journal 28 4 347 358 1:CAS:528: DC%2BD1MXntFGmsQ%3D%3D 19153603
42. S Ries C Biederer D Woods O Shifman S Shirasawa T Sasazuki, et al. 2000 Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF Cell 103 2 321 330 1:CAS:528:DC%2BD3cXns1Clt7o%3D 11057904
43. T Ozaki R Okoshi M Sang N Kubo A Nakagawara 2009 Acetylation status of E2F-1 has an important role in the regulation of E2F-1-mediated transactivation of tumor suppressor p73 Biochemical and Biophysical Research Communications 386 1 207 211 1:CAS:528:DC%2BD1MXnvVagurc%3D 19523927
44. BS Sayan AE Sayan AL Yang RI Aqeilan E Candi GM Cohen, et al. 2007 Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis Proceedings of the National Academy of Sciences of the United States of America 104 26 10871 10876 1:CAS:528:DC%2BD2sXnsV2lurg%3D 17581882
45. N Li H Fu Y Tie Z Hu W Kong Y Wu, et al. 2009 miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells Cancer Letters 275 1 44 53 1:CAS:528:DC%2BD1MXhtVeiurk%3D 19006648
46. A Salvi C Sabelli S Moncini M Venturin B Arici P Riva, et al. 2009 MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells The FEBS Journal 276 11 2966 2982 1:CAS:528:DC%2BD1MXmslaru7o%3D 19490101
47. M Yamakuchi CD Lotterman C Bao RH Hruban B Karim JT Mendell, et al. 2010 p53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis Proceedings of the National Academy of Sciences of the United States of America 107 14 6334 6339 1:CAS:528:DC%2BC3cXkslehsLs%3D 20308559
48. M Sachdeva YY Mo 2010 MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 Cancer Research 70 1 378 387 1:CAS:528:DC%2BC3cXltVWi 19996288
49. X Chen J Gong H Zeng N Chen R Huang, et al. 2010 MicroRNA145 targets BNIP3 and suppresses prostate cancer progression Cancer Research 70 7 2728 2738 1:CAS:528:DC%2BC3cXktFyntr4%3D 20332243
50. T Chiyomaru H Enokida S Tatarano K Kawahara Y Uchida K Nishiyama, et al. 2010 miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer British Journal of Cancer 102 5 883 891 1:CAS:528:DC%2BC3cXis1ygsrw%3D 20160723
51. Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y., Chiyomaru, T., Enokida, H., Nakagawa, M., Matsubara, H. (2010). miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer (in press)
52. CE Barbieri LJ Tang KA Brown JA Pietenpol 2006 Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis Cancer Research 66 15 7589 7597 1:CAS:528:DC%2BD28XnsFyrurg%3D 16885358
53. Boominathan, L. (2010). The Tumor suppressors p53, p63, and p73 inhibit migrating cancer stem cells by increasing the expression of stem cell suppressing miRNAs Nature Precedings, http://hdl.handle.net/10101/npre.2010. 4385.1.
54. Boominathan, L. (2009). p63, p73, & p53 are negative regulators of epithelial to mesenchymal transition (EMT), invasion & metastasis. Nature Precedings http://dx.doi.org/10.1038/npre.2009.4109.1.
55. KG Leong K Niessen I Kulic A Raouf C Eaves I Pollet, et al. 2007 Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin The Journal of Experimental Medicine 204 12 2935 2948 1:CAS:528:DC%2BD2sXhsVSgs7rF 17984306
56. C Hooper M Tavassoli JP Chapple D Uwanogho R Goodyear G Melino, et al. 2006 TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones Journal of Neurochemistry 99 3 989 999 1:CAS:528: DC%2BD28Xht1eju7rI 17076661
57. WK Chu PM Dai HL Li JK Chen 2008 Transcriptional activity of the DeltaNp63 promoter is regulated by STAT3 The Journal of Biological Chemistry 283 12 7328 7337 1:CAS:528:DC%2BD1cXjt1emtbw%3D 18198175
58. H Nishi M Senoo KH Nishi B Murphy T Rikiyama Y Matsumura, et al. 2001 p53 Homologue p63 represses epidermal growth factor receptor expression The Journal of Biological Chemistry 276 45 41717 41724 1:CAS:528:DC%2BD3MXosVGnsbY%3D 11546792
59. HW Lo SC Hsu W Xia X Cao JY Shih Y Wei, et al. 2007 Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression Cancer Research 67 19 9066 9076 1:CAS:528: DC%2BD2sXhtFSnur7L 17909010
60. Cho, M. S., Chan, I. L., & Flores, E. R. (2010). DeltaNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb development, tumorigenesis and metastasis. Cell Cycle, 9(12).
61. RI Fernando M Litzinger P Trono DH Hamilton J Schlom C Palena 2010 The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells The Journal of Clinical Investigation 120 2 533 544 1:CAS:528:DC%2BC3cXhsVOktLg%3D 20071775
62. M Senoo Y Matsumura S Habu 2002 TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression Oncogene 21 16 2455 2465 1:CAS:528:DC%2BD38Xjtlemtb0%3D 11971180
63. AD Yang ER Camp F Fan L Shen MJ Gray W Liu, et al. 2006 Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells Cancer Research 66 1 46 51 1:CAS:528:DC%2BD28XhsFWlsQ%3D%3D 16397214
64. P Mak I Leav B Pursell D Bae X Yang CA Taglienti, et al. 2010 ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading Cancer Cell 17 4 319 332 1:CAS:528:DC%2BC3cXmsF2msLs%3D 20385358
65. MH Yang MZ Wu SH Chiou PM Chen SY Chang CJ Liu, et al. 2008 Direct regulation of TWIST by HIF-1alpha promotes metastasis Nature Cell Biology 10 3 295 305 1:CAS:528:DC%2BD1cXislaksrc%3D 18297062
66. S Ansieau J Bastid A Doreau AP Morel BP Bouchet C Thomas, et al. 2008 Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence Cancer Cell 14 1 79 89 1:CAS:528: DC%2BD1cXos1ektLw%3D 18598946
67. BP Zhou J Deng W Xia J Xu YM Li M Gunduz, et al. 2004 Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nature Cell Biology 6 10 931 940 1:CAS:528:DC%2BD2cXnvFGqs7o%3D 15448698
68. H Fukushima F Koga S Kawakami Y Fujii S Yoshida E Ratovitski, et al. 2009 Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway Cancer Research 69 24 9263 9270 1:CAS:528:DC%2BD1MXhsFGrtbjO 19934319
69. S Shin CA Dimitri SO Yoon W Dowdle J Blenis 2010 ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events Molecular Cell 38 1 114 127 1:CAS:528:DC%2BC3cXlvFynsbY%3D 20385094
70. K Higashikawa S Yoneda K Tobiume M Saitoh M Taki, et al. 2009 DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma International Journal of Cancer 124 12 2837 2844 1:CAS:528:DC%2BD1MXltlCgtbw%3D
71. R Kommagani MK Leonard S Lewis RA Romano S Sinha MP Kadakia 2009 Regulation of VDR by deltaNp63alpha is associated with inhibition of cell invasion Journal of Cell Science 122 Pt 16 2828 2835 1:CAS:528: DC%2BD1MXhtFOgsb%2FO 19622632
72. R Kommagani V Payal MP Kadakia 2007 Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage The Journal of Biological Chemistry 282 41 29847 29854 1:CAS:528: DC%2BD2sXhtFagtb3E 17716971
73. HG Pálmer JM González-Sancho J Espada MT Berciano I Puig J Baulida, et al. 2001 Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling The Journal of Cell Biology 154 2 369 387 11470825
74. HG Pálmer MJ Larriba JM García P Ordóñez- Morán C Peña S Peiró, et al. 2004 The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer Natural Medicines 10 9 917 919
75. C Peña JM García J Silva V García R Rodríguez I Alonso, et al. 2005 E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations Human Molecular Genetics 14 22 3361 3370 16203744
76. K Higashikawa S Yoneda K Tobiume M Taki H Shigeishi 2007 Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma Cancer Research 67 19 9207 9213 1:CAS:528:DC%2BD2sXhtFSnurzP 17909026
77. D Aberdam K Gambaro P Rostagno E Aberdam S de la Forest Divonne M Rouleau 2007 Key role of p63 in BMP-4-induced epidermal commitment of embryonic stem cells Cell Cycle 6 3 291 294 1:CAS:528:DC%2BD2sXnvFygt7Y%3D 17264680
78. A Chikh E Sayan S Thibaut AM Lena S DiGiorgi BA Bernard, et al. 2007 Expression of GATA-3 in epidermis and hair follicle: relationship to p63 Biochemical and Biophysical Research Communications 361 1 1 6 1:CAS:528:DC%2BD2sXotlWrt7Y%3D 17632082
79. W Yan QJ Cao RB Arenas B Bentley R Shao 2010 GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition The Journal of Biological Chemistry 285 18 14042 14051 1:CAS:528: DC%2BC3cXltFOgtbw%3D 20189993
80. H Kouros-Mehr SK Bechis EM Slorach LE Littlepage M Egeblad AJ Ewald, et al. 2008 GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model Cancer Cell 13 2 141 152 1:CAS:528:DC%2BD1cXitFWrs7Y%3D 18242514
81. AB Dydensborg AA Rose BJ Wilson D Grote M Paquet V Giguère, et al. 2009 GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis Oncogene 28 29 2634 2642 1:CAS:528:DC%2BD1MXms1alt7Y%3D 19483726
82. E Candi A Terrinoni A Rufini A Chikh AM Lena Y Suzuki, et al. 2006 p63 is upstream of IKK alpha in epidermal development Journal of Cell Science 119 Pt 22 4617 4622 1:CAS:528:DC%2BD2sXktF2l 17093266
83. P Descargues AK Sil M Karin 2008 IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer The EMBO Journal 27 20 2639 2647 1:CAS:528:DC%2BD1cXht1KrtLbN 18818691
84. B Marinari C Ballaro MI Koster ML Giustizieri F Moretti F Crosti, et al. 2009 IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias The Journal of Investigative Dermatology 129 1 60 69 1:CAS:528:DC%2BD1cXhsVymu7%2FP 18633439
85. MI Koster D Dai B Marinari Y Sano A Costanzo M Karin, et al. 2007 p63 induces key target genes required for epidermal morphogenesis Proceedings of the National Academy of Sciences of the United States of America 104 9 3255 3260 1:CAS:528:DC%2BD2sXjtVWlsbY%3D 17360634
86. C Beretta A Chiarelli B Testoni R Mantovani L Guerrini 2005 Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63 Cell Cycle 11 1625 1631
87. DK Carroll JS Carroll CO Leong F Cheng M Brown AA Mills, et al. 2006 p63 regulates an adhesion programme and cell survival in epithelial cells Nature Cell Biology 6 551 561
88. K Sato Y Tomizawa H Iijima R Saito T Ishizuka T Nakajima, et al. 2006 Epigenetic inactivation of the RUNX3 gene in lung cancer Oncology Reports 15 1 129 135 1:CAS:528:DC%2BD28XmsFeltA%3D%3D 16328045
89. M Zamisch L Tian R Grenningloh Y Xiong KF Wildt M Ehlers, et al. 2009 The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus The Journal of Experimental Medicine 206 12 2685 2699 1:CAS:528:DC%2BD1MXhsV2ltr3I 19917777
90. KS Lee YS Lee JM Lee K Ito S Cinghu JH Kim, et al. 2010 Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer Oncogene 29 23 3349 3361 1:CAS:528:DC%2BC3cXjt1Ogtbo%3D 20228843
91. TL Chang K Ito TK Ko Q Liu M Salto-Tellez KG Yeoh, et al. 2010 Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells Gastroenterology 138 1 255 265 1:CAS:528:DC%2BC3cXht1ajtro%3D 19706291 e1-3
92. T Lopardo N Lo Iacono B Marinari ML Giustizieri DG Cyr G Merlo, et al. 2008 Claudin-1 is a p63 target gene with a crucial role in epithelial development PLoS ONE 3 7 e2715 18648642
93. YC Chao SH Pan SC Yang SL Yu TF Che CW Lin, et al. 2009 Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma American Journal of Respiratory and Critical Care Medicine 179 2 123 133 1:CAS:528:DC%2BD1MXitFCktrk%3D 18787218
94. AH Berger M Niki A Morotti BS Taylor ND Socci A Viale, et al. 2010 Identification of DOK genes as lung tumor suppressors Nature Genetics 42 3 216 223 1:CAS:528:DC%2BC3cXhs1Olur0%3D 20139980
95. M Niki A Di Cristofano M Zhao H Honda H Hirai L Van Aelst, et al. 2004 Role of Dok-1 and Dok-2 in leukemia suppression The Journal of Experimental Medicine 200 12 1689 1695 1:CAS:528:DC%2BD2cXhtFGmurfN 15611295
96. G Wu S Nomoto MO Hoque T Dracheva M Osada CC Lee, et al. 2003 DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development Cancer Research 63 10 2351 2357 1:CAS:528:DC%2BD3sXjsleiu7o%3D 12750249
97. A Zamò G Malpeli A Scarpa C Doglioni M Chilosi F Menestrina 2005 Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas Modern Pathology 18 11 1448 1453 15920542
98. G Pruneri S Fabris P Dell'Orto MO Biasi S Valentini B Del Curto, et al. 2005 The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification The Journal of Pathology 206 3 337 345 1:CAS:528:DC%2BD2MXmvVartb8%3D 15887287
99. M Nicolas MI Koster SL Lu LD White XJ Wang DR Roop 2006 Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression Cancer Research 66 8 3981 3986
100. Y Sasaki S Ishida I Morimoto T Yamashita T Kojima C Kihara, et al. 2002 The p53 family member genes are involved in the Notch signal pathway The Journal of Biological Chemistry 277 1 719 724 1:CAS:528:DC%2BD38XjslGltw%3D%3D 11641404
101. Y Shimomura M Wajid L Shapiro AM Christiano 2008 P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle Development 135 4 743 753 1:CAS:528:DC%2BD1cXjsFyhtrY%3D 18199584
102. K Taniuchi H Nakagawa M Hosokawa T Nakamura H Eguchi H Ohigashi, et al. 2005 Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases Cancer Research 65 8 3092 3099 1:CAS:528:DC%2BD2MXjt1yksbs%3D 15833838
103. T Bui J Sequeira TC Wen A Sola Y Higashi H Kondoh, et al. 2009 ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia PLoS ONE 4 2 e4373 19194497 PLoS One. 4(8):e6816
104. M Nicolas A Wolfer K Raj JA Kummer P Mill M van Noort, et al. 2003 Notch1 functions as a tumor suppressor in mouse skin Nature Genetics 33 3 416 421 1:CAS:528:DC%2BD3sXhsV2kurs%3D 12590261
105. AP Weng AA Ferrando W Lee JP Morris 4th LB Silverman C Sanchez-Irizarry, et al. 2004 Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia Science 306 5694 269 271 1:CAS:528:DC%2BD2cXotFWnsbo%3D 15472075
106. K Lefort A Mandinova P Ostano V Kolev V Calpini I Kolfschoten, et al. 2007 Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases Genes & Development 21 5 562 577 1:CAS:528:DC%2BD2sXjsVSqtb4%3D
107. Q Ji X Hao M Zhang W Tang M Yang L Li, et al. 2009 MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells PLoS ONE 4 8 e6816 19714243
108. T Yugawa M Narisawa-Saito Y Yoshimatsu K Haga S Ohno N Egawa, et al. 2010 DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells Cancer Research 70 10 4034 4044 1:CAS:528:DC%2BC3cXlvFyqsr4%3D 20442293
109. GP Dotto 2009 Crosstalk of Notch with p53 and p63 in cancer growth control Nature Reviews. Cancer 8 587 595
110. JC Schwamborn E Berezikov JA Knoblich 2009 The TRIM-NHL protein TRIM32 activates miRNAs and prevents self-renewal in mouse neural progenitors Cell 136 5 913 925 1:CAS:528:DC%2BD1MXltFSnsLc%3D 19269368
111. I Loedige W Filipowicz 2009 TRIM-NHL proteins take on miRNA regulation Cell 136 5 818 820 1:CAS:528:DC%2BD1MXltFSnsL8%3D 19269362
112. Boominathan, L. (2009). Tumor suppressors function as a bottleneck against cellular reprogramming into iPS cells. Nature Precedings http://dx.doi.org/10.1038/npre.2009.4113.1.
113. L Boominathan 2010 The tumor suppressors p53, p63 and p73 are regulators of miRNA processing complex PLoS ONE 5 5 e10615 20485546
114. MA Viganò J Lamartine B Testoni D Merico D Alotto C Castagnoli, et al. 2006 New p63 targets in keratinocytes identified by a genome-wide approach The EMBO Journal 25 21 5105 5116 17036050
115. M Lee V Vasioukhin 2008 Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor Journal of Cell Science 121 Pt 8 1141 1150 1:CAS:528:DC%2BD1cXmtFaltb4%3D 18388309
116. A Wodarz C Gonzalez 2006 Connecting cancer to the asymmetric division of stem cells Cell 124 6 1121 1123 1:CAS:528:DC%2BD28Xjt1Kiu7Y%3D 16564003
117. Boominathan, L. (2010) The TA-p73 functions as a Lung tumor suppressor by increasing the expression of miRNA, let-7. Nature Precedings http://dx.doi.org/10.1038/npre.2010.4252.1 >.
118. V Tarasov P Jung B Verdoodt D Lodygin A Epanchintsev, et al. 2007 Differential regulation of miRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest Cell Cycle 6 13 1586 1593 1:CAS:528:DC%2BD2sXhtFWlsr3O 17554199
119. JM Rosenbluth DJ Mays MF Pino LJ Tang JA Pietenpol 2008 A gene signature-based approach identifies mTOR as a regulator of p73 Molecular and Cellular Biology 19 5951 5964
120. MS Kumar SJ Erkeland RE Pester CY Chen MS Ebert PA Sharp, et al. 2008 Suppression of non-small cell lung tumor development by the let-7 miRNA family Proceedings of the National Academy of Sciences of the United States of America 105 10 3903 3908 1:CAS:528:DC%2BD1cXjs1Ohs7s%3D 18308936
121. A Esquela-Kerscher P Trang JF Wiggins L Patrawala A Cheng L Ford, et al. 2008 The let-7 miRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 7 6 759 764 1:CAS:528:DC%2BD1cXmvVWqtrk%3D 18344688
122. J Takamizawa H Konishi K Yanagisawa S Tomida H Osada H Endoh, et al. 2004 Reduced expression of the let-7 miRNAs in human lung cancers in association with shortened postoperative surviva Cancer Research 64 11 3753 3756 1:CAS:528:DC%2BD2cXksVKgurs%3D 15172979
123. CD Johnson A Esquela-Kerscher G Stefani M Byrom K Kelnar 2007 The let-7 miRNA represses cell proliferation pathways in human cells Cancer Research 67 16 7713 7722 1:CAS:528:DC%2BD2sXptVGlsbo%3D 17699775
124. DJ Baker C Perez-Terzic F Jin K Pitel NJ Niederländer, et al. 2008 Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency Nature Cell Biology 10 7 825 836 1:CAS:528:DC%2BD1cXnvFSisr0%3D 18516091
125. A Bearzatto D Conte M Frattini N Zaffaroni F Andriani, et al. 2002 p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer Clinical Cancer Research 8 12 3782 3787 1:CAS:528:DC%2BD38XpslCjt7k%3D 12473590
126. M Seike A Gemma Y Hosoya S Hemmi Y Taniguchi, et al. 2000 Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53 Clinical Cancer Research 6 11 4307 4313 1:CAS:528:DC%2BD3cXovVSgurs%3D 11106248
127. H Lee 2003 Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas Experimental & Molecular Medicine 35 5 448 453 1:CAS:528:DC%2BD3sXpsFClu70%3D
128. CG Mullighan S Goorha I Radtke CB Miller E Coustan-Smith JD Dalton, et al. 2007 Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Nature 446 7137 758 764 1:CAS:528:DC%2BD2sXktVeqt7g%3D 17344859
129. A Yang Z Zhu P Kapranov F McKeon GM Church TR Gingeras, et al. 2006 Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells Molecular Cell 24 4 593 602 1:CAS:528:DC%2BD28Xht1yltrzI 17188034
130. J Zhang S Jun Cho X Chen 2010 RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability Proceedings of the National Academy of Sciences of the United States of America 107 21 9614 9619 1:CAS:528:DC%2BC3cXntFGqsL8%3D 20457941
131. Boominathan, L. (2006) Role of c-Jun in the regulation of the tumor suppressor p53 homologue, p73. Ph.D thesis, National University of Singapore, https://scholarbank.nus.edu.sg/handle/10635/15006.
132. AM Lena R Shalom-Feuerstein P Rivetti di Val Cervo D Aberdam RA Knight G Melino, et al. 2008 miR-203 represses 'stemness' by repressing DeltaNp63 Cell Death and Differentiation 15 7 1187 1195 1:CAS:528:DC%2BD1cXntFOltro%3D 18483491
133. HK Lin Z Chen G Wang C Nardella SW Lee CH Chan, et al. 2010 Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence Nature 464 7287 374 379 1:CAS:528:DC%2BC3cXjsFWjs7s%3D 20237562
134. CH Chan SW Lee CF Li J Wang WL Yang CY Wu, et al. 2010 Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis Nature Cell Biology 12 5 457 467 1:CAS:528:DC%2BC3cXlsFGgsrs%3D 20383141
135. S Zhang Q Tang F Xu Y Xue Z Zhen Y Deng, et al. 2009 RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors Molecular Cancer Research 7 4 570 580 1:CAS:528:DC%2BD1MXks1antbY%3D 19372585
136. D Tedesco J Lukas SI Reed 2002 The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2) Genes & Development 16 22 2946 2957 1:CAS:528:DC%2BD38XovVejsbw%3D
137. M Kitagawa SH Lee F McCormick 2008 Skp2 suppresses p53-dependent apoptosis by inhibiting p300 Molecular Cell 29 2 217 231 1:CAS:528: DC%2BD1cXhvVOks7o%3D 18243116
138. B Belletti MS Nicoloso M Schiappacassi S Berton F Lovat K Wolf, et al. 2008 Stathmin activity influences sarcoma cell shape, motility, and metastatic potential Molecular Biology of the Cell 19 5 2003 2013 1:CAS:528: DC%2BD1cXlslels7s%3D 18305103
139. UB Keller JB Old FC Dorsey JA Nilsson L Nilsson KH MacLean, et al. 2007 Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis The EMBO Journal 26 10 2562 2574 1:CAS:528:DC%2BD2sXlt1Kksb8%3D 17464290
140. BE Schaffer KS Park G Yiu JF Conklin C Lin DL Burkhart, et al. 2010 Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma Cancer Research 70 10 3877 3883 1:CAS:528:DC%2BC3cXlvFyrtL0%3D 20406986
141. S Gonzalez P Klatt S Delgado E Conde F Lopez-Rios M Sanchez-Cespedes, et al. 2006 Oncogenic activity of Cdc6 through repression of the INK4/ARF locus Nature 440 7084 702 706 1:CAS:528:DC%2BD28XivFWgtbc%3D 16572177
142. M Adorno M Cordenonsi M Montagner S Dupont C Wong B Hann, et al. 2009 A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis Cell 137 1 87 98 1:CAS:528:DC%2BD1MXls1Srsrk%3D 19345189
143. SR Viswanathan JT Powers W Einhorn Y Hoshida T Ng S Toffanin, et al. 2009 Lin28 enhances tumorigenesis and is associated with advanced human malignancies Nature Genetics 41 7 843 848 1:CAS:528:DC%2BD1MXms1aktrk%3D 19483683
144. YS Lee A Dutta 2007 The tumor suppressor miRNA let-7 represses the HMGA2 oncogene Genes & Development 21 9 1025 1030 1:CAS:528:DC%2BD2sXltFCnsrs%3D
145. J Nishino I Kim K Chada SJ Morrison 2008 Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression Cell 135 2 227 239 1:CAS:528:DC%2BD1cXhtlWhsr%2FL 18957199
146. S Thuault EJ Tan H Peinado A Cano CH Heldin A Moustakas 2008 HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to- mesenchymal transition The Journal of Biological Chemistry 283 48 33437 33446 1:CAS:528:DC%2BD1cXhsVSgt73P 18832382
147. P Klanrit P Taebunpakul MB Flinterman EW Odell MA Riaz G Melino, et al. 2009 PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers Oncogene 28 39 3499 3512 1:CAS:528:DC%2BD1MXosFWhsb4%3D 19597475
148. ME Peter 2009 Let-7 and miR-200 miRNAs: guardians against pluripotency and cancer progression Cell Cycle 8 6 843 852 1:CAS:528:DC%2BD1MXlvFWis7k%3D 19221491
149. B Boyerinas SM Park N Shomron MM Hedegaard J Vinther JS Andersen, et al. 2008 Identification of let-7-regulated oncofetal genes Cancer Research 68 8 2587 2591 1:CAS:528:DC%2BD1cXks1GitL4%3D 18413726
150. J Yu MA Vodyanik K Smuga-Otto J Antosiewicz-Bourget JL Frane S Tian, et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells Science 318 5858 1917 1920 1:CAS:528:DC%2BD2sXhsVGjsLbN 18029452
151. HJ Mao J Perez-losada J Wu R DelRosario R Tsunematsu KI Nakayama, et al. 2004 Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene Nature 432 775 779 1:CAS:528:DC%2BD2cXhtVGmtb7L 15592418
152. KG Sim Z Zang CM Yang JV Bonventre SI Hsu 2004 TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability Cell Cycle 3 10 1296 1304 1:CAS:528:DC%2BD2MXhtFChu7vE 15467469
153. W Welcker A Orian J Jin JA Grim JW Harper RN Eisenman, et al. 2004 The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation- dependent c-Myc protein degradation Proceedings of the National Academy of Sciences of the United States of America 101 24 9085 9090 1:CAS:528: DC%2BD2cXltlWqsbo%3D 15150404
154. I Onoyama R Tsunematsu A Matsumoto T Kimura IM de Alborán K Nakayama, et al. 2007 Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis The Journal of Experimental Medicine 204 12 2875 2888 1:CAS:528:DC%2BD2sXhsVSgs73F 17984302
155. S Matsuoka Y Oike I Onoyama A Iwama F Arai K Takubo 2008 Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL Genes & Development 22 8 986 991 1:CAS:528: DC%2BD1cXltVOisLo%3D
156. M Sachdeva S Zhu F Wu H Wu V Walia S Kumar, et al. 2009 p53 represses c-Myc through induction of the tumor suppressor miR-145 Proceedings of the National Academy of Sciences of the United States of America 106 9 3207 3212 1:CAS:528:DC%2BD1MXivF2jsrg%3D 19202062
157. X Liu LF Sempere F Galimberti SJ Freemantle C Black KH Dragnev, et al. 2009 Uncovering growth-suppressive MiRNAs in lung cancer Clinical Cancer Research 15 4 1177 1183 1:CAS:528:DC%2BD1MXitVOksb0%3D 19228723
158. L Yamasaki T Jacks R Bronson E Goillot E Harlow NJ Dyson 1996 Tumor induction and tissue atrophy in mice lacking E2F-1 Cell 85 4 537 548 1:CAS:528:DyaK28XjtFyit70%3D 8653789
159. TC Chang LR Zeitels HW Hwang RR Chivukula EA Wentzel M Dews, et al. 2009 Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation Proceedings of the National Academy of Sciences of the United States of America 106 9 3384 3389 1:CAS:528:DC%2BD1MXivF2jsbg%3D 19211792
160. L He JM Thomson MT Hemann E Hernando-Monge D Mu S Goodson, et al. 2005 A miRNA polycistron as a potential human oncogene Nature 435 7043 828 833 1:CAS:528:DC%2BD2MXkvVGgs70%3D 15944707
161. A Ernst B Campos J Meier F Devens F Liesenberg M Wolter, et al. 2010 De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures Oncogene 29 23 3411 3422 1:CAS:528: DC%2BC3cXjs1Kisr0%3D 20305691
162. JT Mendell 2008 miRiad roles for the miR-17-92 cluster in development and disease Cell 133 2 217 222 1:CAS:528:DC%2BD1cXltlWnurY%3D 18423194 Review
163. A Alimonti C Nardella Z Chen JG Clohessy A Carracedo LC Trotman, et al. 2010 A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis The Journal of Clinical Investigation 120 3 681 693 1:CAS:528:DC%2BC3cXjtV2nsrc%3D 20197621
164. H Matsubara T Takeuchi E Nishikawa K Yanagisawa Y Hayashita H Ebi, et al. 2007 Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 Oncogene 26 41 6099 6105 1:CAS:528:DC%2BD2sXpvFWmtbg%3D 17384677
165. EJ Morris JY Ji F Yang L Di Stefano A Herr NS Moon, et al. 2008 E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8 Nature 455 7212 552 556 1:CAS:528:DC%2BD1cXhtFKhtLbE 18794899
166. C Zhao J Blum A Chen HY Kwon SH Jung JM Cook, et al. 2007 Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo Cancer Cell 6 528 541
167. SA Stuart Y Minami JY Wang 2009 The CML stem cell: evolution of the progenitor Cell Cycle 8 9 1338 1343 1:CAS:528:DC%2BD1MXmvFCitbk%3D 19342894
168. HL Yan G Xue Q Mei YZ Wang FX Ding MF Liu, et al. 2009 Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis The EMBO Journal 28 18 2719 2732 1:CAS:528:DC%2BD1MXpvFCktbg%3D 19696742
169. MJ Bueno M Gomez de Cedrón U Laresgoiti J Fernández- Piqueras A Zubiaga M Malumbres 2010 Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signalling Molecular and Cellular Biology 12 2983 2995
170. P Mu YC Han D Betel E Yao M Squatrito P Ogrodowski, et al. 2009 Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas Genes & Development 23 24 2806 2811 1:CAS:528:DC%2BC3cXntFKj
171. RE Rempel S Mori M Gasparetto MA Glozak ER Andrechek SB Adler, et al. 2009 A role for E2F activities in determining the fate of Myc-induced lymphomagenesis PLoS Genetics 5 9 e1000640 19749980
172. TC Chang D Yu YS Lee EA Wentzel DE Arking KM West, et al. 2008 Widespread miRNA repression by Myc contributes to tumorigenesis Nature Genetics 40 1 43 50 1:CAS:528:DC%2BD1cXhtVyqtQ%3D%3D 18066065
173. P Gao I Tchernyshyov TC Chang YS Lee K Kita T Ochi, et al. 2009 c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 7239 762 765 1:CAS:528:DC%2BD1MXhvFKjtrY%3D 19219026
174. K Watanabe T Ozaki T Nakagawa K Miyazaki M Takahashi, et al. 2002 Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function The Journal of Biological Chemistry 277 17 15113 15123 1:CAS:528:DC%2BD38XjslSgtLg%3D 11844794
175. E Horvilleur M Bauer D Goldschneider X Mergui A de la Motte, et al. 2008 p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells Nucleic Acids Research 36 13 4222 4232 1:CAS:528:DC%2BD1cXptVCgtr4%3D 18583365
176. S Giuriato S Ryeom AC Fan P Bachireddy RC Lynch MJ Rioth, et al. 2006 Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch Proceedings of the National Academy of Sciences of the United States of America 103 44 16266 16271 1:CAS:528:DC%2BD28Xht1WmsL3E 17056717
177. M Fabbri R Garzon A Cimmino Z Liu N Zanesi E Callegari, et al. 2007 MiRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proceedings of the National Academy of Sciences of the United States of America 104 40 15805 15810 1:CAS:528:DC%2BD2sXhtFGns7zL 17890317
178. R Garzon S Liu M Fabbri Z Liu CE Heaphy E Callegari, et al. 2009 MiRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 113 25 6411 6418 1:CAS:528:DC%2BD1MXnvFGns7c%3D 19211935
179. E Deneault S Cellot FA Laverdure FM JP J Chagraoui, et al. 2009 Functional screen to identify novel effectors of hematopoietic stem cell activity Cell 137 2 369 379 1:CAS:528:DC%2BD1MXmvVahsrY%3D 19379700
180. H Wang R Garzon H Sun KJ Ladner R Singh J Dahlman, et al. 2008 NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma Cancer Cell 14 5 369 381 1:CAS:528:DC%2BD1cXhtlOjsLrM 18977326
181. Y Park JH Lee M Ha JW Nam VN Kim 2009 miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42 Nature Structural & Molecular Biology 16 1 23 29 1:CAS:528:DC%2BD1cXhsV2hsrvF
182. AU Sinha V Kaimal J Chen AG Jegga 2008 Dissecting microregulation of a master regulatory network BMC Genomics 9 88 18294391
183. A Lujambio GA Calin A Villanueva S Ropero M Sánchez- Céspedes D Blanco, et al. 2008 A miRNA DNA methylation signature for human cancer metastasis Proceedings of the National Academy of Sciences of the United States of America 105 36 13556 13561 1:CAS:528:DC%2BD1cXhtFeqs7bF 18768788
184. AM Duursma M Kedde M Schrier C le Sage R Agami 2008 miR-148 targets human DNMT3b protein coding region RNA 14 5 872 877 1:CAS:528:DC%2BD1cXls1Wrtrg%3D 18367714
185. M Kato J Zhang M Wang L Lanting H Yuan JJ Rossi, et al. 2007 MiRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors Proceedings of the National Academy of Sciences of the United States of America 104 9 3432 3437 1:CAS:528:DC%2BD2sXjtVWltLo%3D 17360662
186. CJ Braun X Zhang I Savelyeva S Wolff UM Moll T Schepeler, et al. 2008 p53-Responsive miRNAs 192 and 215 are capable of inducing cell cycle arrest Cancer Research 68 24 1094 1104
187. SA Georges MC Biery SY Kim JM Schelter J Guo AN Chang, et al. 2008 Coordinated regulation of cell cycle transcripts by p53-Inducible miRNAs, miR-192 and miR-215 Cancer Research 68 24 10105 10112 1:CAS:528: DC%2BD1cXhsV2it7fM 19074876
188. PA Gregory AG Bert EL Paterson SC Barry A Tsykin G Farshid, et al. 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nature Cell Biology 10 5 593 601 1:CAS:528: DC%2BD1cXltl2is7c%3D 18376396
189. CP Bracken PA Gregory N Kolesnikoff AG Bert J Wang MF Shannon, et al. 2008 A double-negative feedback loop between ZEB1-SIP1 and the miRNA-200 family regulates epithelial-mesenchymal transition Cancer Research 68 19 7846 7854 1:CAS:528:DC%2BD1cXhtF2msLzK 18829540
190. CA Gebeshuber K Zatloukal J Martinez 2009 miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis EMBO Reports 10 4 400 405 1:CAS:528:DC%2BD1MXisVShtbY%3D 19247375
191. S Sengupta JA den Boon IH Chen MA Newton SA Stanhope YJ Cheng, et al. 2008 MiRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins Proceedings of the National Academy of Sciences of the United States of America 105 15 5874 5878 1:CAS:528:DC%2BD1cXltVyhtbc%3D 18390668
192. L Qin L Liao A Redmond L Young Y Yuan H Chen, et al. 2008 The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression Molecular and Cellular Biology 19 5937 5950
193. T Zenz J Mohr E Eldering AP Kater A Buhler D Kienle, et al. 2009 MiR-34a as part of the resistance network in chronic lymphocytic leukemia Blood 113 16 3801 3808 1:CAS:528:DC%2BD1MXlt1yjsbw%3D 18941118
194. L He X He LP Lim E de Stanchina Z Xuan Y Liang, et al. 2007 miRNA component of the p53 tumour suppressor network Nature 447 7148 1130 1134 1:CAS:528:DC%2BD2sXmvFKmu7c%3D 17554337
195. L He X He SW Lowe GJ Hannon 2007 miRNAs join the p53 network-another piece in the tumour-suppression puzzle Nature Reviews. Cancer 7 11 819 822 1:CAS:528:DC%2BD2sXht1Wgsb%2FF 17914404 Review
196. F Sun H Fu Q Liu Y Tie J Zhu R Xing, et al. 2008 Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest FEBS Letters 582 10 1564 1568 1:CAS:528:DC%2BD1cXkvVOhsrg%3D 18406353
197. A Aslanian PJ Iaquinta R Verona JA Lees 2004 Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics Genes & Development 18 12 1413 1422 1:CAS:528:DC%2BD2cXltFKrtLk%3D
198. Q Ji X Hao Y Meng M Zhang J Desano D Fan, et al. 2008 Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres BMC Cancer 8 266 18803879
199. S Wang Y Yuan L Liao SQ Kuang JC Tien BW O'Malley, et al. 2009 Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation Proceedings of the National Academy of Sciences of the United States of America 106 1 151 156 1:CAS:528:DC%2BD1MXlsF2qsg%3D%3D 19109434
200. L Qin Z Liu H Chen J Xu 2009 The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis Cancer Research 69 9 3819 3827 1:CAS:528:DC%2BD1MXltFOks7Y%3D 19383905
201. DX Nguyen AC Chiang XH Zhang JY Kim MG Kris M Ladanyi, et al. 2009 WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis Cell 138 1 51 62 1:CAS:528:DC%2BD1MXps1ygur8%3D 19576624
202. D Bonci V Coppola M Musumeci A Addario R Giuffrida L Memeo, et al. 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities Natural Medicines 14 11 1271 1277 1:CAS:528: DC%2BD1cXhtlCjtL3O
203. U Klein M Lia M Crespo R Siegel Q Shen T Mo, et al. 2010 The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia Cancer Cell 17 1 28 40 1:CAS:528: DC%2BC3cXkvFKgs7o%3D 20060366
204. A Cimmino GA Calin M Fabbri MV Iorio M Ferracin M Shimizu, et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2 Proceedings of the National Academy of Sciences of the United States of America 102 39 13944 13949 1:CAS:528:DC%2BD2MXhtVOqsbjK 16166262
205. GA Calin A Cimmino M Fabbri M Ferracin SE Wojcik M Shimizu, et al. 2008 MiR-15a and miR-16-1 cluster functions in human leukemia Proceedings of the National Academy of Sciences of the United States of America 105 13 5166 5171 1:CAS:528:DC%2BD1cXksVCqs70%3D 18362358
206. A Chatterjee X Chang T Sen R Ravi A Bedi D Sidransky 2010 Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta Cancer Research 70 4 1419 1429 1:CAS:528: DC%2BC3cXhvFaksL4%3D 20145131
207. Boominathan, L. (2009) Curcumin functions a positive regulator of miRNA processing and a negative regulator of stem cell proliferation. Nature Precedings, http://dx.doi.org/10.1038/npre.2009.4110.1
208. JS Dovey SJ Zacharek CF Kim JA Lees 2008 Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion Proceedings of the National Academy of Sciences of the United States of America 105 33 11857 11862 1:CAS:528:DC%2BD1cXhtVCnurvK 18697930
209. MJ Bueno M Gómez de Cedrón U Laresgoiti J Fernández-Piqueras AM Zubiaga M Malumbres 2010 Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling Molecular and Cellular Biology 30 12 2983 2995 1:CAS:528:DC%2BC3cXotFGqs7g%3D 20404092
210. S Sander L Bullinger K Klapproth K Fiedler HA Kestler TF Barth, et al. 2008 MYC stimulates EZH2 expression by repression of its negative regulator miR-26a Blood 112 10 4202 4212 1:CAS:528:DC%2BD1cXhsVSmsrvI 18713946
211. S Sander L Bullinger T Wirth 2009 Repressing the repressor: a new mode of MYC action in lymphomagenesis Cell Cycle 8 4 556 559 1:CAS:528: DC%2BD1MXlvFWjtL8%3D 19197161
212. S Fujii A Ochiai 2008 Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells Cancer Science 99 4 738 746 1:CAS:528:DC%2BD1cXlsFKmtbc%3D 18377425
213. S Fujii K Ito Y Ito A Ochiai 2008 Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation The Journal of Biological Chemistry 283 25 17324 17332 1:CAS:528:DC%2BD1cXntFSntb0%3D 18430739
214. Q Cao J Yu SM Dhanasekaran JH Kim RS Mani SA Tomlins, et al. 2008 Repression of E-cadherin by the polycomb group protein EZH2 in cancer Oncogene 27 58 7274 7284 1:CAS:528:DC%2BD1cXhsVylsb%2FM 18806826
215. L Beke M Nuytten A Van Eynde M Beullens M Bollen 2007 The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2 Oncogene 26 31 4590 4595 1:CAS:528:DC%2BD2sXnt1entbs%3D 17237810
216. X Yang RK Karuturi F Sun M Aau K Yu R Shao, et al. 2009 CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells PLoS ONE 4 4 e5011 19340297
217. E Ezhkova HA Pasolli JS Parker N Stokes IH Su G Hannon, et al. 2009 Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells Cell 136 6 1122 1135 1:CAS:528:DC%2BD1MXltFSnt70%3D 19303854
218. J Kota RR Chivukula KA O'Donnell EA Wentzel CL Montgomery, et al. 2009 Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 6 1005 1017 1:CAS:528:DC%2BD1MXps1eiurg%3D 19524505
219. JM Friedman G Liang CC Liu EM Wolff YC Tsai, et al. 2009 The putative tumor suppressor miRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2 Cancer Research 69 6 2623 2629 1:CAS:528: DC%2BD1MXjtF2jsr4%3D 19258506
220. J Faber AV Krivtsov MC Stubbs R Wright TN Davis M van den Heuvel-Eibrink, et al. 2009 HOXA9 is required for survival in human MLL-rearranged acute leukemias Blood 113 11 2375 2385 1:CAS:528:DC%2BD1MXjsFKhuro%3D 19056693
221. BD Rowland R Bernards DS Peeper 2005 The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene Nature Cell Biology 7 11 1074 1082 1:CAS:528:DC%2BD2MXht1WqtrvE 16244670
222. Y Li Z Zhou C Chen 2008 WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis Cell Death and Differentiation 15 12 1941 1951 1:CAS:528:DC%2BD1cXhtlyjsb3I 18806757
223. Yu, F., Deng, H., Yao, H., Liu, Q., Su, F., Song, E. (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene (in press)
224. Braun, J., Hoang-Vu, C., Dralle, H., Hüttelmaier, S. (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene (in press)
225. TC Chang EA Wentzel OA Kent K Ramachandran M Mullendore KH Lee, et al. 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Molecular Cell 26 5 745 752 1:CAS:528:DC%2BD2sXnt1Cquro%3D 17540599
226. WY Kim S Perera B Zhou J Carretero JJ Yeh SA Heathcote, et al. 2009 HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice The Journal of Clinical Investigation 119 8 2160 2170 1:CAS:528:DC%2BD1MXpsFCluro%3D 19662677
227. Z Li S Bao Q Wu H Wang C Eyler S Sathornsumetee, et al. 2009 Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 6 501 513 1:CAS:528:DC%2BD1MXntlegtbo%3D 19477429
228. B Keith MC Simon 2007 Hypoxia-inducible factors, stem cells, and cancer Cell 129 3 465 472 1:CAS:528:DC%2BD2sXlvVGktbw%3D 17482542 Review
229. JD Gordan MC Simon 2007 Hypoxia-inducible factors: central regulators of the tumor phenotype Current Opinion in Genetics & Development 17 1 71 77 1:CAS:528:DC%2BD2sXnslOntw%3D%3D Review
230. EH Gort AJ Groot E van der Wall PJ van Diest MA Vooijs 2008 Hypoxic regulation of metastasis via hypoxia-inducible factors Current Molecular Medicine 8 1 60 67 1:CAS:528:DC%2BD1cXjs1agsbw%3D 18289014 Review
231. K Jazdzewski EL Murray K Franssila B Jarzab DR Schoenberg A de la Chapelle 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proceedings of the National Academy of Sciences of the United States of America 105 20 7269 7274 1:CAS:528:DC%2BD1cXmsFCqsLo%3D 18474871
232. K Jazdzewski S Liyanarachchi M Swierniak J Pachucki MD Ringel B Jarzab, et al. 2009 Polymorphic mature miRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer Proceedings of the National Academy of Sciences of the United States of America 106 5 1502 1505 1:CAS:528:DC%2BD1MXhvV2qurg%3D 19164563
233. SL Lin A Chiang D Chang SY Ying 2008 Loss of mir-146a function in hormone-refractory prostate cancer RNA 14 3 417 424 1:CAS:528: DC%2BD1cXivFaqs7o%3D 18174313
234. DR Hurst MD Edmonds GK Scott CC Benz KS Vaidya DR Welch 2009 Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis Cancer Research 69 4 1279 1283 1:CAS:528:DC%2BD1MXhslygu7c%3D 19190326
235. TT Onder PB Gupta SA Mani J Yang ES Lander RA Weinberg 2008 Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Research 68 10 3645 3654 1:CAS:528:DC%2BD1cXlvVOitLw%3D 18483246
236. SA Mani W Guo MJ Liao EN Eaton A Ayyanan AY Zhou, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 4 704 715 1:CAS:528:DC%2BD1cXmsVOru7w%3D 18485877
237. Y Khew-Goodall GJ Goodall 2010 Myc-modulated miR-9 makes more metastases Nature Cell Biology 12 3 209 211 1:CAS:528:DC%2BC3cXisFemsLs%3D 20173743
238. L Ma J Young H Prabhala E Pan P Mestdagh D Muth, et al. 2010 miR-9, a MYC/MYCN-activated miRNA, regulates E-cadherin and cancer metastasis Nature Cell Biology 12 3 247 256 1:CAS:528:DC%2BC3cXisFems7g%3D 20173740
239. SC Smith D Theodorescu 2009 Learning therapeutic lessons from metastasis suppressor proteins Nature Reviews. Cancer 9 4 253 264 1:CAS:528: DC%2BD1MXitlGlsbg%3D 19242414
240. JW Kim S Mori JR Nevins 2010 Myc-induced MicroRNAs integrate Myc-mediated cell proliferation and cell fate Cancer Research 70 12 4820 4828 1:CAS:528:DC%2BC3cXntlKltrg%3D 20516112
241. M Garofalo G Di Leva G Romano G Nuovo SS Suh A Ngankeu, et al. 2009 miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation Cancer Cell 16 6 498 509 1:CAS:528: DC%2BC3cXht1eqsbk%3D 19962668
242. F Fornari L Gramantieri M Ferracin A Veronese S Sabbioni GA Calin, et al. 2008 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma Oncogene 27 43 5651 5661 1:CAS:528:DC%2BD1cXhtFKhsLbO 18521080
243. CH Wu J van Riggelen A Yetil AC Fan P Bachireddy DW Felsher 2007 Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation Proceedings of the National Academy of Sciences of the United States of America 104 32 13028 13033 1:CAS:528:DC%2BD2sXpt1Krtbo%3D 17664422
244. I Guney S Wu JM Sedivy 2006 Reduced c-Myc signaling triggers telomere independent senescence by regulating Bmi-1 and p16(INK4a) Proceedings of the National Academy of Sciences of the United States of America 103 10 3645 3650 1:CAS:528:DC%2BD28XivFWju7s%3D 16537449
245. A Nemajerova O Petrenko L Trümper G Palacios UM Moll 2010 Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice The Journal of Clinical Investigation 120 6 2070 2080 1:CAS:528:DC%2BC3cXnt1Kqtbw%3D 20484818
246. H Zheng H Ying H Yan AC Kimmelman DJ Hiller AJ Chen, et al. 2008 p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation Nature 455 7216 1129 1133 1:CAS:528:DC%2BD1cXht1yju7rE 18948956
247. Liu, X., Karnell, JL., Yin, B., Zhang, R., Zhang, J., Li, P., et al. (2010) Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest (in press)
248. W Guo JL Lasky CJ Chang S Mosessian X Lewis Y Xiao, et al. 2008 Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation Nature 453 7194 529 533 1:CAS:528:DC%2BD1cXmt1Ortb8%3D 18463637
249. S Yanagi H Kishimoto K Kawahara T Sasaki M Sasaki M Nishio, et al. 2007 Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice The Journal of Clinical Investigation 117 10 2929 2940 1:CAS:528:DC%2BD2sXhtFCnt7rL 17909629
250. L Du A Pertsemlidis 2010 microRNAs and lung cancer: tumors and 22-mers Cancer and Metastasis Reviews 29 1 109 122 1:CAS:528:DC%2BC3cXitVOjtLo%3D 20130964 Review
251. MA Gregory Y Qi SR Hann 2005 The ARF tumor suppressor: keeping Myc on a leash Cell Cycle 4 2 24952
252. SA Nicholson NT Okby MA Khan JA Welsh MG McMenamin WD Travis, et al. 2001 Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma Cancer Research 61 14 5636 5643 1:CAS:528:DC%2BD3MXlsVChtrY%3D 11454718
253. K Inoue A Mallakin DP Frazier 2007 Dmp1 and tumor suppression Oncogene 26 30 4329 4335 1:CAS:528:DC%2BD2sXntVCju74%3D 17237816 Review
254. A Mallakin T Sugiyama P Taneja LA Matise DP Frazier M Choudhary, et al. 2007 Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer Cancer Cell 12 4 381 394 1:CAS:528:DC%2BD2sXht1ais7zK 17936562
255. K Inoue T Sugiyama P Taneja RL Morgan DP Frazier 2008 Emerging roles of DMP1 in lung cancer Cancer Research 68 12 4487 4490 1:CAS:528: DC%2BD1cXnt1aqsL0%3D 18559489 Review
256. Malone Hannon 2009 Small RNAs as guardians of the genome Cell 136 656 668 1:CAS:528:DC%2BD1MXkvFGksbo%3D 19239887
257. Y Xi R Shalgi O Fodstad Y Pilpel J Ju 2006 Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer Clinical Cancer Research 12 7 Pt 1 2014 2024 1:CAS:528:DC%2BD28XjtlCiu7w%3D 16609010
258. WE Theurkauf C Klattenhoff DP Bratu N McGinnis-Schultz BS Koppetsch HA Cook 2006 rasiRNAs, DNA damage, and embryonic axis specification Cold Spring Harbor Symposia on Quantitative Biology 71 171 180 1:CAS:528: DC%2BD2sXls1yrsbs%3D 17381294
259. C Kutter P Svoboda 2008 miRNA, siRNA, piRNA: knowns of the unknown RNA Biology 5 4 181 188 1:CAS:528:DC%2BD1MXhvVKluw%3D%3D 19182524
260. Boominathan, L. (2009). The guardians of the genome dependent tumor suppressor miRNAs network Nature Precedings, http://dx.doi.org/10.1038/npre. 2009.4112.1